CollPlant Biotechnologies (CLGN) EPS (Basic) (QoQ) (2018 - 2026)
CollPlant Biotechnologies (CLGN) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - |
| 10 | CollPlant Biotechnologies | 4.33 Mn | 4.33 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 91.35% |
| Dec 31, 2025 | -850.76% |
| Sep 30, 2025 | -1,165,728,891.04% |
| Jun 30, 2025 | 100.00% |
| Mar 30, 2025 | 65.04% |
| Dec 31, 2024 | -4.85% |
| Sep 30, 2024 | -1,215,135,235.14% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | -7.04% |
| Sep 30, 2023 | -918,531,909.35% |
| Jun 30, 2023 | 53.21% |
| Mar 31, 2023 | -17.17% |
| Dec 31, 2022 | -2.03% |
| Sep 30, 2022 | 2.56% |
| Jun 30, 2022 | 5.37% |
| Mar 31, 2022 | 185.34% |
| Dec 31, 2021 | -41.67% |
| Sep 30, 2021 | -193.90% |
| Jun 30, 2021 | -79.38% |